After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Dr. James McCaffrey presents a complete end-to-end demonstration of anomaly detection using k-means data clustering, ...
Researchers discovered that adding instructions for AI-powered browser assistants after the hash (#) symbol inside URLs can influence their behavior to leak sensitive data and direct users to phishing ...
Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...
Transformer on MSNOpinion
The problem with DeepSeek
But there’s a big problem — DeepSeek does not appear to have conducted any predeployment safety testing. There is no mention ...
The Architects of AI drove the economy, shaped geopolitics, and changed the way we interact with the world. by Charlie Campbell, Andrew R. Chow and Billy Perrigo by Sam Jacobs by D.W. Pine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback